Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons A. (Ahmad) Kurniawan

Publicaties

[123I]Italia: A PARP-Directed Auger Electron-Emitting Agent for Targeted Radionuclide Therapy of Cancer

Bridging the gaps in fibroblast activation protein targeted radionuclide therapy: a translational perspective

[¹⁶¹Tb]Tb-DOTA-PSMA I&T Exerts Antitumour Effects and Induces Immune Activation in 2D and 3D Prostate Cancer Coculture Models

Is radiolabelling a PARP inhibitor with a radiometal via a DOTA chelator a viable strategy for PARP-targeted radionuclide therapy (TRT)?

Synthesis and in vitro comparison of [18F]bicalutamide and [123I]bicalutamide, two novel androgen receptor radioligands for PET/SPECT imaging

Tumour Heterogeneity in FAP Expression Exposes a Dual Role for FAP-Expressing CAFs in FAP-Targeted Radionuclide Therapy

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijn

Meer informatie over de Sustainable Development Goals.